𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease

✍ Scribed by V. Planté-Bordeneuve; M. B. Davis; D. M. Maraganore; C. D. Marsden; Professor A. E. Harding


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
283 KB
Volume
9
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Tyrosine hydroxylase (TH) is a theoretical candidate gene determining susceptibility to Parkinson's disease (PD), and an association between one allele of a polymorphism at the TH locus and sporadic PD has been reported. We investigated TH polymorphism in 44 patients with sporadic PD, 48 patients with familial PD and 89 of their unaffected relatives, and 50 control subjects. No evidence of allelic association was detected in either familial or sporadic PD, and linkage analysis excluded the TH locus, or a closely linked gene, as a major determinant of familial PD.


📜 SIMILAR VOLUMES


Do polymorphisms in the familial Parkins
✍ Greg T. Sutherland; Glenda M. Halliday; Peter A. Silburn; Frank L. Mastaglia; Do 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract Recent whole genome association studies provided little evidence that polymorphisms at the familial Parkinsonism loci influence the risk for Parkinson's disease (PD). However, these studies are not designed to detect the types of subtle effects that common variants may impose. Here, we

The role of parkin in familial and spora
✍ Ted M. Dawson; Valina L. Dawson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Mutations in parkin are the second most common known cause of Parkinson's disease (PD). Parkin is an ubiquitin E3 ligase that monoubiquitinates and polyubiquitinates proteins to regulate a variety of cellular processes. Loss of parkin's E3 ligase activity is thought to play a pathogenic

G2019S LRRK2 mutation in familial and sp
✍ Sofya N. Pchelina; Andrei F. Yakimovskii; Olga N. Ivanova; Anton K. Emelianov; A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine‐rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwester

Rarity of debrisoquine hydroxylase gene
✍ Dr. Chi P. Pang; Jun Zhang; Jean Woo; Daniel Chan; Lap K. Law; Shirley F. Tong; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

## Abstract Impaired debrisoquine metabolism resulting from defects in the cytochrome P450 __CYP2D6__‐debrisoquine hydroxylase gene has been shown to be associated with the development of Parkinson's disease(PD). We studied two polymorphisms in this gene in 207 Chinese PD patients and 227 control s

High prevalence of LRRK2 mutations in fa
✍ Joaquim J. Ferreira; Leonor Correia Guedes; Mário Miguel Rosa; Miguel Coelho; Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Mutations in the __Leucine‐Rich Repeat Kinase 2__ (__LRRK2__) gene are the most frequent known cause of Parkinson's disease (PD), but their prevalence varies markedly between populations. Here we studied the frequency and associated phenotype of four recurrent __LRRK2__ mutations (R1441